Risk-Adapted Therapy With Three or Six Cycles of Doxorubicin/Bleomycin/Vinblastine/Dacarbazine Plus Involved-Field Radiation Therapy in Hodgkin Lymphoma, Based on Prognosis at Diagnosis and Early Response: Results From the GATLA Study
Authors:
- Santiago PavlovskySPSantiago Pavlovsky
- Claudia CorradoCCClaudia Corrado
- Miguel A. PavlovskyMPMiguel A. Pavlovsky
- María V. PratesMPMaría V. Prates
- Lucía ZoppegnoLZLucía Zoppegno
- Mario GiuntaMGMario Giunta
- Ider CeruttiICIder Cerutti
- Elsa PalominoEPElsa Palomino
- Fernando PaganiFPFernando Pagani
- Francisco LastiriFLFrancisco Lastiri
- Daniel BarDBDaniel Bar
- Raimundo F. BezaresRBRaimundo F. Bezares
- 1 June 2010
- journal article
- clinical trial
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 10 (3) , 181-185
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2005
- Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin diseaseBlood, 2004
- ABVD Plus Subtotal Nodal Versus Involved-Field Radiotherapy in Early-Stage Hodgkin's Disease: Long-Term ResultsJournal of Clinical Oncology, 2004
- Consolidation Radiation After Complete Remission in Hodgkin's Disease Following Six Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy: Is There a Need?Journal of Clinical Oncology, 2004
- Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup TrialJournal of Clinical Oncology, 2003
- Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.Journal of Clinical Oncology, 1997
- Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.Journal of Clinical Oncology, 1993
- Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVDNew England Journal of Medicine, 1992
- Randomized Trial of Chemotherapy Versus Chemotherapy Plus Radiotherapy for Stage I-II Hodgkin's DiseaseJNCI: Journal of the National Cancer Institute, 1988
- Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.Journal of Clinical Oncology, 1987